|
|
|
|
|
|
|
|
|
|
|
Problems Leveraging the Investment in your Research Data?
|
Virtual Chemistry can help you develop strategies to maximize your investment and accelerate
the drug discovery process.
Please contact us at
650.620.0090 (office)
info@VirtualChemistry.com
contact us
|
|
|
 |
The discovery process leading to drugs for the treatment of human diseases is a highly
cross-disciplinary and collaborative effort involving scientists, clinicians and
business experts, often in multi-site, multi-organization research settings. Effective
decision making in such an environment relies on effective management, annotation,
integration, analysis, and reporting across complex, disparate data sources.
These requirements present significant challenges for pharmaceutical and biotechnology
companies. Driven in large part by the rapid progress in biomedical sciences; information
and knowledge is now often too copious and complex for individual researchers to effectively
assimilate, conceptualize, synthesize, and apply consistently in the process of drug discovery.
This explosive growth of scientific data has created the need for a new generation of tools
and techniques for collaborative scientific data management. Such tools will enable life
science companies to maximize their extensive R&D investments to increase revenue, accelerate
time to market, and improve research productivity - all while operating in a highly-regulated environment.
|
|
|
|
"Virtual Chemistry was responsive, creative, and understood the complexity of our project. They used their dual command of chemical structures and graphics to provide a superb image which effectively conveyed an otherwise complicated comparison of biomolecules."
|
|
|
|
Catherine M. Polizzi, Ph.D., J.D.
|
|
Partner
|
|
Morrison & Foerster LLP
|
|
|
|
|
|
|
|
|
